Alan B. Lancz & Associates, Inc. Sanofi Transaction History
Alan B. Lancz & Associates, Inc.
- $100 Million
- Q2 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Sanofi stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 6,300 shares of SNY stock, worth $349,524. This represents 0.3% of its overall portfolio holdings.
Number of Shares
6,300
Previous 6,510
3.23%
Holding current value
$349,524
Previous $323,000
5.57%
% of portfolio
0.3%
Previous 0.34%
Shares
8 transactions
Others Institutions Holding SNY
# of Institutions
795Shares Held
252MCall Options Held
2.6MPut Options Held
1.64M-
Dodge & Cox San Francisco, CA77.1MShares$4.28 Billion2.36% of portfolio
-
Morgan Stanley New York, NY14.7MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.6MShares$754 Million0.29% of portfolio
-
Bank Of America Corp Charlotte, NC11.2MShares$622 Million0.05% of portfolio
-
Invesco Ltd. Atlanta, GA10.5MShares$583 Million0.11% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $139B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...